Safety Results From MPOWERED, a Phase 3 Trial of Oral Octreotide Capsules in Adults With Acromegaly

Background: Injectable somatostatin receptor ligands (iSRLs) have been a mainstay in acromegaly treatment. Oral octreotide capsules (OOC; MYCAPSSA(®)) were recently approved in the United States. Results from the placebo-controlled CHIASMA OPTIMAL and open-label CH-ACM-01 studies showed an OOC safet...

Descripción completa

Detalles Bibliográficos
Autores principales: Freda, Pamela, Fleseriu, Maria, Dreval, Akexander V, Pokramovich, Yulia, Bondar, Irina, Isaeva, Elena, Huang, Wenyu, Molitch, Mark E, Macut, Djuro P, Leonova, Nina, Raverot, Gerald, Gilgun-Sherki, Yossi, Ludlam, William H, Patou, Gary, Haviv, Asi, Gordon, Murray B, Biermasz, Nienke, Melmed, Shlomo, Strasburger, Christian J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090593/
http://dx.doi.org/10.1210/jendso/bvab048.1074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090593/
http://dx.doi.org/10.1210/jendso/bvab048.1074

Ejemplares similares